Otsuka’s Alzheimer Drug AVP-786 Fails Trial Phase by Lilu Anderson 13.02.2024 Otsuka's phase 3 trial for AVP-786 in treating agitation in Alzheimer's patients has failed to meet the primary efficacy endpoint. ...
Revolutionizing Health Predictions: MIT and Google Unveil AI Framework by Lilu Anderson 24.01.2024 Discover how wearable sensor technology is revolutionizing healthcare and advancing personalized healthcare analytics. Learn more in this groundbreaking research article.